Orthofix Medical Inc... Show more
Orthofix Medical Inc. (OFIX) is a global medical technology company specializing in spine and limb reconstruction solutions. Shares of the company declined sharply, closing the most recent completed session at $12.15 before falling to a latest available price of $10.335. This represents a 14.94% drop, driven primarily by an updated outlook that reflects lower expected revenue growth due to recent Medicare reimbursement adjustments.
The main driver behind today’s decline was Orthofix’s announcement that it has lowered its 2026 financial guidance. The revision stems from recent changes in Medicare reimbursement policies affecting certain spine and orthopedic procedures. Management indicated that these adjustments are expected to temper revenue growth for the remainder of the year, prompting a more conservative forecast.
Trading volume was notably higher than the recent average, signaling strong investor reaction to the outlook revision. The decline in OFIX shares aligned with softness across the broader medical device sector, while major indices posted modest gains. Technically, the stock broke below key near-term support levels, accelerating selling pressure during the session.
Tickeron’s Trending AI Robots page showcases the strongest-performing AI trading bots under current market conditions. The platform offers hundreds of AI-powered bots that trade thousands of tickers across various strategies, timeframes, and performance metrics. Only top performers are featured in this curated section, providing traders with data-driven insights into automated strategies. Explore the latest trends and discover bots suited to your trading style.
Investors will monitor upcoming quarterly results for further details on execution and any additional commentary regarding reimbursement impacts. Analyst expectations remain focused on revenue trends and margin performance amid the evolving regulatory environment. Key risks include continued policy changes and sector-wide reimbursement pressures that could affect future growth.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OFIX advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OFIX's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where OFIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
OFIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on May 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFIX as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for OFIX turned negative on May 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
OFIX moved below its 50-day moving average on May 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFIX crossed bearishly below the 50-day moving average on May 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for OFIX entered a downward trend on May 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.956) is normal, around the industry mean (10.901). P/E Ratio (0.000) is within average values for comparable stocks, (61.230). OFIX's Projected Growth (PEG Ratio) (48.825) is very high in comparison to the industry average of (3.717). OFIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.498) is also within normal values, averaging (26.806).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of surgical products to the spine and orthopedic markets
Industry MedicalNursingServices